Aurum Pharmaceuticals Private Limited
About Aurum Pharmaceuticals Private Limited
Data last updated:
Aurum Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 June 1961 and has been in existence for over 65 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1961PTC012053.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.98 Lakh. It is led by directors including Ashok Damodardas Bhuta and Neha Rajiv Shanghvi.
Its last annual general meeting (AGM) was held on 30 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 30 – D Parsi Panchayat Road Andheri (East), Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.58 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹5.38 Lakh (net margin 71%) and EBITDA of ₹7.2 Lakh (EBITDA margin 95%). Revenue has declined at a compounded annual rate (CAGR) of 2% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Aurum Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address30 – D Parsi Panchayat Road Andheri (East), Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aurum Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aurum Pharmaceuticals Private Limited
FY 2020 filings availableAurum Pharmaceuticals Private Limited reported revenue of ₹7.58 Lakh (up 15% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.58 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95% | ||||
| Net Profit Margin | 71% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aurum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aurum Pharmaceuticals Private Limited
Aurum Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashok Damodardas Bhuta Also directs: Bhuta Constructions and Realty LLP | Director | 01 Apr 1990 | 36 Years 7 Months | Current |
| Neha Rajiv Shanghvi | Director | 25 Jun 2018 | 8 Years 4 Months | Current |
| Naresh Damodardas Bhuta | Director | 01 Jun 1969 | 57 Years 5 Months | Current |
Peer comparison
Aurum Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Search Pharma Private Limited | ₹7.6 Lakh (FY 2025) | -53.0% | New Delhi, Delhi, India | |||
| Eldritch Pharmaceuticals Private Limited | ₹7.6 Lakh (FY 2024) | -1.0% | New Delhi, Delhi, India | |||
| Lenimax Pharmaceuticals Private Limited | ₹7.59 Lakh (FY 2021) | 0.0% | Hyderabad, Telangana, India | |||
| Ashlite Pharmaceuticals Private Limited | ₹7.59 Lakh (FY 2025) | Dadri, Uttar Pradesh, India | ||||
| Mediwin Bio Healthcare Private Limited | ₹7.59 Lakh (FY 2025) | -1.0% | Ahmedabad, Gujarat, India | |||
| Aurum Pharmaceuticals Private Limitedthis company | ₹7.58 Lakh (FY 2020) | ₹5.38 Lakh | 71% | 15.0% | Mumbai, Maharashtra, India | |
| Impac Pharmaceuticals Private Limited | ₹7.57 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Eden Tulip Pharmaceuticals Private Limited | ₹7.56 Lakh (FY 2018) | 9.0% | Delhi, India | |||
| Eosin Pharmaceuticals Private Limited | ₹7.55 Lakh (FY 2025) | Pune, Maharashtra, India | ||||
| Adreno Pharmaceuticals Private Limited | ₹7.54 Lakh (FY 2025) | -24.0% | Rohini New, Delhi, India | |||
| Yajas Pharmaceuticals Private Limited | ₹7.53 Lakh (FY 2024) | 161.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Aurum Pharmaceuticals Private Limited, buy the company report.
Auditor
Aurum Pharmaceuticals Private Limited is audited by M B RAJPUT & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M B RAJPUT & ASSOCIATES | FY 2020 | 113034W |
Shareholding
The shareholding of Aurum Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aurum Pharmaceuticals Private Limited, buy the company report.
Legal cases
Aurum Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Aurum Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai Small Causes Court, Maharashtra | Court case (TER) | Filed by the company against Ms. Indira Rashtriya Kamgar Sakhari Soc. Ltd. | Disposed |
To see the full case history of Aurum Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aurum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aurum Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aurum Pharmaceuticals Private Limited has 5 board changes on record since 1969: 3 appointments and 2 cessations. The latest: Neha Rajiv Shanghvi ceased to be Director on 17 Sep 2021.
Frequently asked questions
Aurum Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 June 1961 (65+ years old) and is registered under CIN U24239MH1961PTC012053.
Aurum Pharmaceuticals has 3 current directors:
- Ashok Damodardas Bhuta - Director
- Neha Rajiv Shanghvi - Director
- Naresh Damodardas Bhuta - Director
The latest financial statements of Aurum Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 30 September 2020. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Aurum Pharmaceuticals is U24239MH1961PTC012053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurum Pharmaceuticals has 1 court case on record: 1 filed by the company.
Aurum Pharmaceuticals was incorporated on 30 June 1961, making it 65+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aurum Pharmaceuticals by revenue are Search Pharma Private Limited, Eldritch Pharmaceuticals Private Limited, Lenimax Pharmaceuticals Private Limited, Ashlite Pharmaceuticals Private Limited, Mediwin Bio Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Neha Rajiv Shanghvi ceased to be Director on 17 Sep 2021. Neha Rajiv Shanghvi was appointed as Director on 25 Jun 2018. Damodardas Bhaidas Bhuta ceased to be Director on 17 Sep 2015. Aurum Pharmaceuticals has 5 board changes on record in total.
The registered office of Aurum Pharmaceuticals is at 30 – D Parsi Panchayat Road Andheri East, Mumbai, Maharashtra, India – 400069.
Aurum Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Aurum Pharmaceuticals is active non-compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
